Showing 30 results
  • Video
    lock
    Video
    Security of supply

    We must work together to protect the security of medicine supply - learn more about the ways we can ensure this is a reality for all Europeans.

  • Video
    lock
    Video
    Orphan Medicinal Products & Pediatrics

    When it comes to orphan and paediatric medicines, a collaborative approach is essential.

  • Video
    lock
    Video
    Regulatory (EMA)

    A smart and future-proof framework can foster innovation in the EU while ensuring faster and widespread access to medicines.

  • Video
    lock
    Video
    Intellectual property, including regulatory data protection (RDP)

    The EU has an opportunity to ensure that we create a predictable and robust framework that leads to more investments and treatments for patients.

  • Video
    lock
    Novartis Access / Video
    Access to medicines in EU Member States

    While everyone agrees that better access to medicines is important, the challenge with using the regulatory framework to achieve this objective is that it's not the right tool for the task.

  • screen-the-unseen-unbranded-newborn-screening-video
    Video
    lock
    Disease Awareness / Video
    Screen the Unseen: Newborn Screening for SMA

    Early signs of spinal muscular atrophy can be subtle, and often go unseen by clinicians – which is why newborn screening is critical to help obtain a prompt diagnosis.

  • gtx-north-carolina-facility-overview-video
    Video
    lock
    Science & Innovation / Video
    Gene Therapy Manufacturing in North Carolina

    A new, state-of-the-art gene therapy manufacturing facility in North Carolina, USA

  • Managing the TSC Transition to Adult Care
    Video
    lock
    Disease Awareness / Video
    Managing the TSC Transition to Adult Care

    Ann describes how to live with symptoms as an adult living with Tuberous Sclerosis Complex (TSC) .

  • What do you know about noncommunicable diseases?
    Video
    lock
    Corporate Responsibility / Video
    What do you know about noncommunicable diseases?

    The menace of noncommunicable diseases (NCDs) like cardiovascular disease, diabetes and cancer in the developing world is increasing. New solutions like Novartis Access are needed to ensure more people are trained to prevent, diagnose and treat these diseases, and patients have access to affordable quality medicines.

  • The Museum of MS
    Video
    lock
    Disease education / Video
    The Museum of MS

    Welcome to the first-ever Museum of MS, a place that celebrates how people living with multiple sclerosis (MS) overcome the challenges or adapt to the symptoms of MS in their daily lives.

  • Novartis and the International Red Cross partner to provide medicines to Syrian refugees
    Video
    lock
    Corporate Responsibility / Video
    Novartis and the International Red Cross partner to provide medicines to Syrian refugees

    Novartis Access is partnering with the International Committee of the Red Cross to provide access to medicines for Syrian refugees and their host communities in Lebanon.

  • Novartis Access: How We'll Expand Access to Healthcare
    Video
    lock
    Corporate Responsibility / Video
    Novartis Access: How We'll Expand Access to Healthcare

    Novartis brought together European stakeholder including NGOs, academia, governments as well as Novartis associates to present and debate Novartis Access, a new program intended to increase access to medicine for patience at ever level of income. Novartis associates share their reactions.